Gary Cutter, MS Ph.D.
Dr. Cutter is a Professor of Biostatistics and Head of the Section on Research Methods and Clinical Trials (RMCT Section) at the UAB School of Public Health. Dr. Cutter has a major interest in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research. He directs three multinational coordinating centers; the CombiRx – combination therapy trial in MS; MGTX – a surgical trial in Myasthenia Gravis, both funded by NINDS and the NARCOMS registry of over 36,000 MS patients funded by the Consortium of MS Centers and private sources. He directs two Coordinating Centers in premature infants, both multi-center trials funded by the Lung Division of NHLBI. He is Deputy Director of the Operations Center for the Neurofibromatosis Consortium and the Director, Biostatistics/Bioinformatics Resource (BBR) Core for the Obrien Center for Acute Kidney Injury Research, UAB-USC (NIDDK); Director, Center For Aids Research, Biostatistics Core, UAB (NIAID) and other multicenter trials. He is a member of the Executive Committee of the UAB CCTS, one of the NIH CTSA projects. He is a member of numerous data and safety monitoring committees for the NIH, Pharmaceutical Companies and foundations. He has been active in evaluation and outcome measures especially the Multiple Sclerosis Functional Composite.